A new strategy for cancer gene therapy has been substrate, linamarin, followed by cell death. We show that developed using a plant gene which encodes the enzyme, the system can eradicate very large intracerebral gliomas linamarase, that hydrolyzes the cyanogenic glucoside subin vivo helped by a cyanide bystander effect. Animals strate, linamarin, into glucose, acetone and cyanide. Retroshowing a total regression of the tumor by magnetic resonviral vectors that carry linamarase as a potential killer-suicance imaging (MRI), do not show other appreciable toxic ide gene cause a marked sensitization to the innocuous effects.
Introduction
The use of a plant gene represents a novel therapy for cancer. A number of strategies have been developed in the past to sensitize tumor cells to specific prodrugs. One of the most successful approaches to date is the herpes simplex thymidine kinase (Hstk)/ganciclovir system. [1] [2] [3] HsTK (the corresponding protein products to genes written in italic are in capital letters) phosphorylates nucleoside analogs (such as ganciclovir or acyclovir) that normal eukaryotic cells fail to phosphorylate. The incorporation of these analogs into the replicating DNA blocks the process, thereby killing the cell. Malignant brain tumors (glioblastoma) have been cured in the rat animal model provided the volume of the tumor does not exceed 100-150 mm 3 in size. 4 When the same treatment is applied to humans, [4] [5] [6] [7] complete remission of the tumor is not achieved, although there is in some cases a measurable size reduction probably responsible for a considerable increase in the expected survival time of these patients. 4, 7 A more aggressive killer-suicide system would represent a promising strategy for one of the most frequent (1 per 50 000 people per year) and deadly (mortality close to 100%) brain tumors in human beings. We have developed an alternative system to pre-existing ones, based upon the plant linamarase gene from cassava (Manihot esculenta Crantz). 8 The enzyme encoded by this gene is a ␤-glucosidase that hydrolyzes the innocuous substrate linamarin (2-H0-isobutyronitrile-␤-d-glucopyranoside) to acetone cyanohydrin and glucose ( Figure 1a) . 8, 9 Acetone cyanohydrin is unstable at pH above 6 and spontaneously breaks down to acetone and HCN. 10 The cyanogenic glucoside, linamarin, is not hydrolyzed by most mammalian tissues, therefore once absorbed, in the absence of linamarase, it is excreted unchanged in the urine. 11, 12 The LD 50 dose of orally administered linamarin is 300 mg linamarin per kilogram of body weight. 11 The novelty of the system we are describing is the use of a plant gene to release cyanide in neoplastic retrovirusexpressing cells, with the potential of causing a large bystander effect among neighboring cells. We hypothesize that a substantial bystander killing effect of the cyanide would counteract the poor estimates (1-10%) for in vivo retroviral infection of solid tumors. The present work demonstrates that transduction of mouse, rat and human cells by retroviral vectors expressing the cassava linamarase gene, cas5, 9 drastically increases sensitivity of these cells to the cytotoxic effects of linamarin in vitro and in vivo. Neighboring cells can also be affected by the cyanide released, thereby amplifying the killing effect.
Results
Construction of a retroviral vector carrying the linamarase gene, linamarin sensitivity of infected cells and toxicity to sodium cyanide A therapeutic retrovirus was engineered by inserting the linamarase gene (cas5) into the Moloney murine leukemia based vector pBabepuro. 13 The resulting recombinant retroviral plasmid carries the cas5 gene expressed under the control of the 5′ LTR (long terminal repeat) promoter, and the selection gene, pac (puromycin N-acetyl transferase), under control of the SV40 promoter ( Figure  1b) . The estimated size of the retroviral plasmid is 6.9 kb and it was designated pLlinSp (plasmid, LTR, linamarase, SV40 promoter, puromycin N-acetyl transferase). Amphotropic retroviral packaging cells ⌿CRIP were grown in increasing amounts of linamarin to determine the sensitivity of these cells to the compound. Values up to 2 mg/ml of linamarin did not markedly decrease cell survival values. No cyanide was detected in any type of cell line tested (C6, ⌿CRIP and 3T3) even after treatment with very high concentrations of linamarin (5 mg/ml, 48 h), showing the stability of the substrate and the absence of linamarase activity in these mammalian cells.
The ecotropic murine packaging cell line ⌿CRE was transfected by the retroviral plasmid vector pLlinSp and supernatants from ⌿CRElin lawns, were collected to infect ⌿CRIP cells producing titers of 3-6 × 10 5 c.f.u. (colony forming units)/ml. Some clones showed a marked toxicity to the presence of linamarin, with estimated concentrations that resulted in 50% cytotoxicity (IC 50 ), of 32 ± 25 g linamarin/ml (Table 1 and Figure 2a) .
In a similar way, rat glioblastoma cells C6 were infected with ⌿CRElin supernatant and about 20 clones resistant to puromycin were selected. In general, the IC 50 of the C6lin clones was 14 times higher than ⌿CRIPlin individual clones (Table 1) , while comparison of best clone values gave an IC 50 of 59 times higher for C6lin than ⌿CRIPlin (Table 1 and Figure 2a and b). The packaging cell line FlyA13 (human fibrosarcoma in origin) has an intermedian IC 50 value of 205 g linamarin/ml at pH 7.4 ( Figure 2c ). Other cell lines whose IC 50 were estimated showed values closer to C6lin than to ⌿CRIPlin (Table 1) .
We can not fully explain the extraordinary low IC 50 value estimated for ⌿CRIPlin but it could be related to a very high linamarin permeability of these particular cells. Cell extracts from C6lin cells incubated with linamarin produced higher amounts of cyanide (purple colour) than equivalent extracts from ⌿CRIPlin cells, suggesting a very efficient expression of the linamarase gene in the C6lin cells (Figure 3) . Isolation of mRNA and Northern hybridization with cas5 confirmed the results of the enzyme assays (data not shown).
The toxicity of sodium cyanide upon the cells was also evaluated. The glioblastoma tumor cell lines (C6, L9 or U373 MG), as well as one glioblastoma explant from a human patient, were 10 to 500 times more resistant to the toxic effect of exogenous sodium cyanide than ⌿CRIP cells. This finding could be related to the observation that malignant tumor cells (C6) have a low oxidative respiration rate and a decreased number of mitochondria, making them more resistant to metabolic poisons, such as KCN, 14, 15 a property that can be partly reversed in vivo by the low pH conditions maintained within the tumor. Neoplastic cells forming a tumor are exposed to a substantial and consistent decrease in extracellular pH from 7.4 to 6.6 in the case of glioblastoma, or lower for other types of tumors 16, 17 resulting in higher sensitivity (50% or greater) to the inhibitory effects of sodium cyanide. Nutrient deprivation due to poor vascularization within solid tumors is probably the major cause of this acidity, with limited oxygen diffusion causing induction of anerobic glycolysis and lactic acid acumulation.
In vitro, cultures are normally maintained closer to pH 7.4 than 6.6. Lowering the culture pH to 6.6 reduced slightly the IC 50 of the best ⌿CRIPlin clone to linamarin from 7.2 g/ml to 4.5 g/ml (Figure 2a) . Although the only significant difference between values in this graph is at 10 g linamarin/ml; the IC 50 of C6lin cells to linamarin drops from 430 g/ml at pH 7.4 to 240 g/ml at pH 6.6, being significant for all concentrations but the highest (Figure 2b) . In a similar way, the IC 50 of FLYA13 cells to linamarin drops from 205 g/ml to 77 g/ml at pH 6.6. The lower interstitial pH in tumors compared with normal tissues would result in a greater and specific sensitivity to the toxic effect of cyanide on tumor cells. This is very convenient because it will selectively increase the In these cell lines the concentration of linamarin was increased to 5 mg/ml without a substantial drop in survival values. In the other cell lines the effect of 5 mg linamarin/ml was not determined. specificity of the therapeutic action towards inner tumor cells rather than normal surrounding cells.
The cyanide bystander effect
The type of bystander effect expected in the present system is rather different from the more commonly described killing of nearby unmodified cells which is dependent on connexin expression and cell communication via gap junctions. 18, 19 The cyanide ion (CN − ) can diffuse freely and HCN is a gas, therefore toxicity to the neighbors of a linamarase-containing cell is due to cyanide release, and cyanide action does not require cell-tocell contact or gap junctions.
In order to investigate the bystander effect in this system, we performed some experiments in which linamarase retroviral producer cells were mixed in a 50:50 initial cell ratio with non-producer cells. One of the two population cells was labeled in red in order to follow its fate. Cells were seeded in flat-sided tubes provided with screw caps to prevent HCN release. One of the mixtures was the packaging cell line ⌿CRIP infected with the pLlinSp retrovirus (⌿CRIPlin) plus normal C6 labeled red with DiI (1,1′-dioctedecyl-3,3,3′,3′-tetramethyl-indocar- bocyanine perchlorate). 20 In the presence of 2 mg/ml of linamarin, both types of cells (⌿CRIPlin and C6-labeled) died; while 86% of C6 alone survived at linamarin concentrations of 10 mg/ml. During the 48-h experimental time, some C6 cells are expected to be infected by the retrovirus rather than die as a consequence of the bystander effect. Mixtures of ⌿CRIPlin with either ⌿CRIP or 3T3 labeled in red (⌿CRIPlin/⌿CRIP red or ⌿CRIPlin/3T3 red) were devastated at a low concentration of linamarin (100 g/ml) due to the greater sensitivity of ⌿CRIP or 3T3 cells to cyanide released by producer cells. In the mixtures ⌿CRIPlin/⌿CRIP red, no infections can take place and all the observed effect is due to bystander mediated by cyanide. These results indicate that the system can be very efficient in neighboring cells compensating for the poor infection estimates for retroviral vectors in solid tumors. 7 Curability of rat glioblastoma in vivo Based on the encouraging in vitro data, we proceeded to evaluate the sensitivity of the system in vivo using an intracerebral tumor model. Two types of experiments were performed: in the first type, C6 cells, already transfected with pLlinSp and selected for puromycin resistance (C6lin), were inoculated into the animal brain and allowed to form a tumor. The glioblastoma would be subsequently treated with the prodrug, linamarin. In the second type of experiment, brain tumors were induced by non-transfected C6 cells and subsequently ⌿CRIPlin retrovirus-producing cells were inoculated into the growing tumor, before treatment with linamarin.
A total of 10 6 C6lin transfected cells were inoculated (in the first type of experiment), into the white matter of the right cerebral hemisphere (4 mm to the right of the bregma and 4.5 mm deep from the skull) of three Wistar rats. A few weeks later (2 to 4), an intracranial tumor was clearly visible by magnetic resonance imaging (around 70 mm 3 volume size) ( Figure 4a 1 and a 2 ) . A day later, linamarin was administered by a direct brain tumor infusion cannula connected by a catheter tube to a mini-osmotic pump. A total of 2.4 mg of linamarin was delivered throughout the 8-day period. Release was at a constant rate of 1 l per h (12.5 g of linamarin/l). The magnetic resonance image taken 3 weeks after the treatment showed a total absence of the tumoral mass and in its place a residual hypointense image at the site of injection, interpreted as a fibrous scar or as the remains of hema- toma with internal hemosiderin (Figure 4b 1 , b 2 ). The animal was killed 7 months later and the brain fixed and processed for microscopic analysis, no tumor cells were found, only a chronic periventricular gliosis. One of the animals having a similar size tumor, was treated with only a total of 1 mg of linamarin, this animal finished the treatment but finally died as a consequence of the tumor, indicating a lower dose limit dosage for the prodrug.
Local, rather than intraperitoneal, administration of the prodrug was chosen, because we have estimated and experimentally confirmed in other systems (tk/ganciclovir or tk/5-2-bromovinyl-2′-deoxyuridine), that the amount of prodrug needed to eradicate 1 mm 3 of tumor is about 1000 times lower if the prodrug is administered locally rather than intraperitoneally (Table 2) , thus decreasing substantially the cost of the treatment. No Table 2 Prodrug dose in micrograms needed to eradicate 1 mm 3 of experimental rat tumor with the system Herpes simplex thymidine kinase/ganciclovir (n = 3)
Prodrug

Intraperitoneal delivery Intracranial delivery
Ganciclovir 3032 ± 2228 20 ± 11 apparent toxicity was observed by local administration of up to 9 mg of linamarin into normal rat brains using the same conditions as in the experimental animals. One of the animals treated with 6 mg of linamarin was killed and the brain fixed and processed for microscopic analysis. No lesion could be detected.
In the second type of experiment, a total of 10 6 C6 cells were inoculated into the right hemisphere of 10 Wistar rats and allowed to develop into tumors. The three animals with the largest tumors, approximate volumes of 400 mm 3 , 600 mm 3 and 1000 mm 3 , (Figure 5a 1 , a 2 and a 3 ), were selected for further inoculation with ⌿CRIPlin retrovirus-producing cells (7 × 10 6 cells for the two smallest and 10 7 cells for the largest) and linamarin local treatment. The murine retroviral-producer cells (⌿CRIPlin) had a titer of 5 × 10 5 c.f.u./ml and were inoculated in a single place (the same used for C6 delivery) in all but the biggest size tumor where an additional small craniotomy was made at a distal site within the tumor, in order to (a 1 , b 1 increase the potential access of retrovirus to all neoplastic cells. A few days later (3 for the largest tumor and 5 for the others), 6 mg of linamarin in 200 l were administered at a constant rate of 1 l per h (osmotic pump delivery). A total eradication of the tumor was achieved for the largest (Figure 5b 1 , b 2 and b 3 ) and the smallest glioblastomas; the medium-sized tumor animal, on the other hand, also finished the treatment but died a month later. Examination of the dead animal brain showed a hemorrhage within the tumor remains, being probably the cause of death.
Control animals (three) with tumor volume sizes (200 mm 3 , 400 mm 3 and 250 mm 3 ), treated only with the linamarin (6 mg) prodrug (no linamarase-producing retrovirus) in the same conditions as described earlier, died: 3, 0 and 2 days before finishing the treatment.
The linamarase/prodrug treated animals showed no apparent neurological damage for a period up to 6 months. We have observed recurrence in very large tumors (over 500 mm 3 in size) about 6 months after finishing the treatment in approximately 50% of the animals. In all recurrent cases the tumoral mass had crossed the interhemispheric fissure and reached the ventricles. At this point tumoral cells could be distributed via cerebrospinal fluid to parts of the brain quite distant from the original inoculum. Indeed some of the recurrent tumors were multiple and very far from the original site.
Toxicity to normal brain tissue was estimated in three animals by direct inoculation of ⌿CRIPlin producer cells, followed by linamarin treatment (2.5, 4 and 6 mg) in the absence of tumor cells. The magnetic resonance of the treated animals ( Figure 6 ) does not show any large damage but a small scar similar to the one normally present in brains after the tumor has been eradicated. Two types of relaxation time (in Tesla, T) images were analyzed: T 1 and T 2 in order to visualize lesions other than tumoral. In general, T 1 -weighted images primarily provide anatomic information, T 2 -weighted images are more sensitive to early pathologic changes in most tissues. We have not seen any lesion related to neoplasm, edema, ischemia, infection, demyelination or trauma; animals only exhibited small MRI abnormalities and no gross lesions. We interpret these results as a proof that the treatment itself does not produce appreciable damage to the brain of the animals.
Discussion
The use of a retrovirus in brain cancer gene therapy has the advantage of targeting only dividing cells in a quiescent background of neurons. The transduction rate of tumor cells by retroviral vectors in vivo is nevertheless very low, being usually in the range of 1-10% of the tumor cell population. An efficient bystander effect is hypothesized to explain the total remission of tumors in animal models by the Hstk/ganciclovir system, and transfer of phosphorylated ganciclovir between cells, via gap junctions, appears as one of the best documented theories to explain the mechanism. 18 Some tumor cells, like rat glioblastoma C6 for example, have lost the capacity to synthesize some of the connexin proteins and therefore the benefit from this important effect will be severely limited. The linamarase/linamarin enzyme/ prodrug combination does not require cell-to-cell contact for its bystander effect, since evidence of cyanide in the cell culture medium indicates that it can cross cell membranes. Furthermore, the bystander effect expected in vivo should be greater than we estimate in vitro since the volatile character of cyanide makes it rather difficult to estimate the killing effect for surrounding cells in vitro because the compound dissipates into the medium and air faster than to neighboring cells. On the other hand, in vivo within a tightly packaged tumor, the cells nearest to the producers will be the first and main target of the cyanide released. Cyanide released within a tumor would also be more effective against neighboring cells by the increased responsive effect of the low extracellular pH. 16 Cells outside the tumor, having extracellular pH values close to 7.4, would be rather resistant to the cyanide bystander effect.
One of the main concerns in the present study is the putative toxicity of the system. Two aspects are particularly delicate and should be further analyzed: one related to the possibility of linamarin breakdown in other parts of the body by alternative enzymes or situations; and the other, to the putative damage of healthy brain tissue surrounding the tumor.
With reference to the first issue, there is one ␤-glucosidase in mammals of broad specificity and obscure physiological function able to hydrolyze toxic plant glycosides found in the diet of man. In general the richest source of this cytosolic ␤-glucosidase in most vertebrates appears to be the liver and the small intestine, except in the mouse and rat, where the kidney is the richest source of the enzyme. 21 , 22 We have confirmed that cyanogenic glycosides, such as linamarin, are not hydrolyzed by cultured mammalian cells: rat brain tumor or normal tissue (Figure 3) , and human brain tumor or normal tissue ( Figure 3 ). Nevertheless gut microbial flora would be able to catabolize some cyanogenic glycosides, such as amygdalin or linamarin, to a certain extent by bacterial ␤-glucosidases in the intestinal lumen. This would result in the release and absorption of hydrogen cyanide. Female hamsters given an oral dose of 108 mg of linamarin/kg body weight show signs of cyanide poisoning causing death in 18% of the animals. 11 The toxicity is much lower in animals receiving similar doses intravenously and is practically absent when administered intraperitoneally. 22 Local administration of linamarin is as safe or probably safer than intraperitoneal delivery since it avoids gastrointestinal interference and it is clear from the in vitro and in vivo tests reported here that we are well below dangerous concentrations of the prodrug. One alternative method for the oral administration of cyanogenic glucosides is to pretreat the animals (or patients) with especially extended-spectrum antibiotics to reduce gastrointestinal flora and therefore make them less susceptible to cyanogenic glucoside toxicity. 23 In many tropical communities a potential health hazard is recognized by the consumption of leaves and roots of the cassava plant. When mechanical damage of the tissues of this plant occurs, the cyanogenic glucoside (linamarin) is exposed to the action of the endogenous plant linamarase and ␣-hydroxynitrile lyase and hydrocyanic acid is released. Cooking/boiling, drying, soaking and fermentation are the usual processing techniques to inactivate linamarase or breakdown linamarin before consumption. The occasional poisoning reported in humans is generally due to inadequately processed leaves or roots. 24 Cyanide doses of 0.5 to 3.5 mg/kg body weight are predicted to be lethal to adults. 25 This would be equivalent to 3 mg/kg of sodium or potassium cyanide and to 500 to 1000 mg of linamarin. The dose of linamarin potentially needed to eradicate a human tumor of about 4 cm diameter, is below dangerous concentrations of the prodrug and would be administered over the period of a week.
The second concern is related to the damage that cyanide release could cause in healthy parts of the brain. Cyanide can rapidly enter the plasmatic membrane and slowly accumulate proportional to the concentration, in mitochondria and membrane elements of the neuronal cell. 26 It is an advantage of our system that the local extracellular pH created within tumors is lower and the susceptibility to cyanide is increased in such conditions. On the other hand, infiltrating glioblastoma cells causing frequent recurrence of the tumor, will probably not benefit from this pH effect.
In one of the in vivo experiments we have performed, a large majority (if not all) of the tumoral cells had incorporated the linamarase gene and therefore could process linamarin to glucose, acetone and cyanide (C6 transfected with pLlinSp). Nevertheless magnetic resonance images show a comparable fibrous scar to the one obtained previously with the Hstk/ganciclovir system 3, 4 or to the C6 infected in vivo by the retrovirus LlinSp, indicating absence of a devastating effect in the brain. The control animals treated with producer cells and linamarin in the absence of tumor ( Figure 6 ) also provide evidence against brain damage with the full treatment. All of the surviving animals are healthy and well, over 6 months after the treatment. We have seen tumor recurrence about 6 months after finishing the treatment, in half of the tumors larger than 500 mm 3 volume size, all of which had originally crossed the interhemispheric fissure and gained access to the lateral ventricles. No recurrence was observed in smaller tumors confined to one brain hemisphere.
Glioblastoma is a particularly nasty tumor because of the infiltrating characteristic of its cellular constituents: recurrence tumors are generally not further than 2 cm from the primary site but it may be difficult to eliminate infiltrated neoplastic cells without damaging some surrounding brain cells. We have been unable in the past, to cure rat glioblastomas larger than 150 mm 3 in volume using the Hstk/ganciclovir system and this indicates that the new linamarase/linamarin approach is more efficient. When the Hstk/ganciclovir system was used in a small number of patients, 4,7,27 a genuine tumor size reduction in about 30% of the treated patients was generally acknowledged, but no total disappearance of the residual tumor has been achieved despite several consecutive treatments. Survival time was increased in many cases, but recurrence finally killed the patient. The method we describe here could certainly be more aggressive than previous ones and the animal results can be considered highly encouraging.
To our knowledge this is the first successful use of a plant gene in the treatment of cancer in vivo. The possibility of applying this procedure to humans remains open and promising.
Materials and methods
Volume estimation
If [0,L] are the parameters of the tumor interval in the sagittal section and C (x), 0 р x р L denotes the area of the corresponding coronal section, then we have the exact formula for the volume of the tumor:
which yields the approximation
In practice, however, we are forced to estimate the volume with the knowledge of only one section of each type. It is not a well-constructed problem. Nevertheless, these tumors are usually adapted to the rat's head geometry: they tend to be rather symmetric (elliptical) in the coronal sections, while they have long and irregular sagittal shapes. Given two 'well-taken' sections, let us introduce coordinates:
A plausible model for the tumor is given by the volume generated placing sections homothetic to C 0 at each position x with a ratio S(x)/d 0 .
Therefore the area ratio is
where C 0 = area of the given coronal section d 0 = diameter of that coronal section in the z (sagittal) direction S(x) = length of the sagittal section in the z direction at position x N will be chosen taking into account the shape of the sagittal picture It is possible to obtain similar formulae replacing sagittal sections by axial. However, taking into consideration the standard geometries of these tumors, the axial section seems to be less significant than the sagittal one. In general, we expect to have an estimate from below using the axial-coronal approach.
Construction of lin-recombinant plasmid
The plasmid pcas 5 9 was first cut with the restriction enzyme SacII and filled in with Klenow, it was subsequently cut with SalI to generate a blunt-ended SalI linamarase coding fragment. This fragment was inserted in pBabe Puro, 13 cut with SnaBI plus SalI restriction enzymes (SnaBI gives a blunt end, so the insert was oriented by the Sal enzyme). The recombinant is called pLlinSp and can be selected by its resistance to puromycin (1-2.5 g/ml puromycin) under control of the promoter of SV40; linamarase is under control of the LTR promoter. The prokaryotic origin of replication allows the recombinant plasmid to grow in bacteria (E. coli) before transduction of mammalian cells.
Cell lines and culture
Cells: C6 and L9 (rat glioblastoma), U373MG (human glioblastoma), Hs683 (human glioma), NIH-3T3 (murine fibroblasts), Ag9181 (human fibroblasts), ⌿CRE (ecotropic packaging line), ⌿CRIP (anphotropic packaging line) and FlYA13 (amphotropic packaging line) were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% heat inactivated fetal calf serum (C6, L9, U373MG, Hs683, Ag9181, FLYA13) and calf serum (the rest). Cells were cultured at 37°C, 7% CO 2 and 97% relative humidity.
The pH of DMEM was artificially lowered to pH 6.6 in some experiments by decreasing the NaHCO 3 concentration from 3.7 g/l to 0.7 g/l.
Transfections and infections
The retroviral plasmid pLlinSp was introduced to the ecotropic ⌿CRE packaging cells using the adenovirus enhanced transferrinfection technique (AVET) for DNA entrance. [28] [29] [30] Viral supernatants from lawns, collected 48 h after transfection, were used to infect amphotropic ⌿CRIP packaging cells (⌿CRIPlin). After selection with puromycin (1.5 g/ml) colonies were isolated using cloning rings. Clonal lines were assayed for vector titer, using NIH 3T3 cells. 6 Best titers were 3-6 × 10 5 c.f.u./ml.
Cell lines showed in Table 1 were infected with ⌿CRI-Plin supernatants (U373MG, Hs683, Ag9181, Sk-N-MC and FLYA13) or ⌿CRElin supernatants (C6 and 3T3), to obtain linamarase producing (lin + ) cell lines. After selection with puromycin, colonies were isolated and linamarin sensitivity was estimated.
In Figure 4 , the inoculated C6 cells were transfected with the retroviral plasmid pLlinSp using the AVET technique for DNA entrance. [28] [29] [30] Labeling of cells Cells were labeled essentially as described previously. 20 Two milligrams of DiI (1,1′-dioctadecyl-3,3,3′ ,3′-tetramethyl-indocarbocyanine perchlorate) were dissolved in 1 ml of ethanol, and 50 l of the solution was added to 5 ml of cells in a 6-cm culture dish. After 1-h incubation at 37°C, the cells were trypsinized, washed twice with PBS, and resuspended in DMEM at a concentration of 5 × 10 4 cells/l.
Linamarin sensitivity and cyanide toxicity assays in culture Cells were seeded in a flat-sided tube (provided with a screw cap to prevent HCN release), at a density of 10 The medium was removed and 3 ml of DMSO (dimethylsulfoxide) were added to dissolve the formazan. Samples were measured spectrophotometrically at 540 nm after 10 min. Cyanide toxicity was assayed as described above except by the addition of increasing amounts of NaCN to the cultures.
Measurements of linamarase activity and cyanide presence Linamarase activity and cyanide presence is determined by the Lambert method 31 with the following modifications: 5 ml of the succinimide/N-chlorosuccinimide reagent was added to the flat tubes, containing the cells with differents amounts of linamarin (48 h later), cultured in 1 ml of DMEM without phenol red. Then 1 ml of the barbituric acid/pyridine reagent was added, mixed and the absorbtion at 592 nm was read after 10 min (calibration curves were made with NaCN).
Tissue homogenates
The tissues were minced and homogenized in five volumes of a medium containing sucrose (0.25 m), ethylenediamine tetraacetate (1 mm) and Tris HCl (0.01 m, pH 7.2) buffer supplemented with the protease inhibitor phenylmethylsulfonyl fluoride (PMSF) (1 mm) all procedures were carried out at 1-4°C. 32 The homogenate was centrifuged (600 g, 10 min) and the supernatant fraction was stored at −70°C. The protein content was measured by BCA protein assay.
The experiment in Figure 3 was carried out at 37°C, 1 mm linamarin, 0.2 mg protein, pH 7.4, in a total volume of 1 ml. Cyanide presence was determined by the Lambert method 31 after 4 h incubation.
Wistar rat brain inoculation of C6lin transfected cells and linamarin administration
We have essentially followed procedures described previously. [3] [4] Wistar male rats weighing 250-300 g were anesthetized with a mixture of ketamine (50 mg/ml), valium (5 mg/ml) and atropine (1mg/ml) in a 5:4:1 ratio by volume at a dose of 0.3 ml/100 g of body weight, before placing them in a stereotactic apparatus. C6 glioma cells or the same cells transfected with the pLlinSp plasmid and selected by puromycin resistance were injected at a concentration of 10 5 cells/l in complete PBS (with calcium and magnesium) supplemented with 0.1% glucose. With the aid of the manipulating arm of the stereotactic apparatus, a total of 10 l was introduced, over a 5-min interval, into the fronto-parietal lobe of the right cerebral hemisphere (4 mm to the right from the bregma and 4.5 mm deep from the skull) using a 10 l Hamilton syringe connected to a 26-gauge needle; the needle was kept in place 3 min before and after injection. ⌿CRIPlin producer cells were inoculated at the same stereotactic coordinates as the C6 cells except in a very large tumor in which an additional tumor site was also used, cells were delivered at different heights along the tumor. All rats received tetracycline in the drinking water (approximately 75 mg/kg) and dexamethasone (1 mg/500 ml) for 3 days before and 1 week after surgery. The linamarin treatment was started after magnetic resonance visualization of the tumor and size estimation. The prodrug was administered by a brain infusion cannula placed at the site of tumor inoculation and fixed to the skull using dental cement; a small stainless steel screw acts as anchor to secure the cannula and the dental cement. The brain infusion cannula was then connected subcutaneously (s.c.) to an osmotic pump (Alzet; model 2001; Alza Pharmaceuticals, Palo Alto, CA, USA) which delivers 1 l/h for 7 or 8 days. The osmotic pump was filled with the appropriate amount of linamarin in PBS.
Magnetic resonance imaging
In this study axial, sagittal and coronal views of the skull were made with a Cpflex small coil around the animal. T1 sagittal and axial projection images were obtained using spin eco, with TR 650, TE 17.0/1 and acquisitions. Slice thickness was 3 mm; field of view 50 × 100 and high resolution matrix of 256 × 512. Sequence post-enhancement was achieved with gadolinium (0.8 ml/kg) and magnetization transfer (MT). government and by the local government: comunidad de Madrid (Acciones coordinadas, grant number 57-1996). The Centro de Biología Molecular is the recipient of an institutional grant from the Fundació n Ramó n Areces.
